封面
市场调查报告书
商品编码
1619304

胰岛素笔市场规模、份额、成长分析,按类型、最终用途、地区 - 产业预测,2024-2031 年

Insulin Pens Market Size, Share, Growth Analysis, By Type (Reusable Insulin Pens, Disposable Insulin Pens), By End-use (Hospitals & Clinics, Homecare), By Region - Industry Forecast 2024-2031

出版日期: | 出版商: SkyQuest | 英文 157 Pages | 商品交期: 3-5个工作天内

价格
简介目录

2022年全球胰岛素笔市场规模为62亿美元,从2023年的77.3亿美元成长到2031年的448.8亿美元,复合年增长率预计为24.6%。

由于糖尿病盛行率不断上升,以及由于易于使用和方便的输送方式而越来越多地采用胰岛素笔,全球胰岛素笔市场正在强劲增长。这些笔由于其易于使用、剂量准确和便携而受到越来越多的糖尿病患者的欢迎,特别是在开发中国家。公认的糖尿病管理优势,以及蓝牙连接和资料追踪功能等技术进步,进一步推动了市场扩张。然而,先进型号的高价格限制了它们在低收入地区的可用性、某些地区的医疗基础设施不足以及製造商为确保符合品质标准而必须遵守的法规的复杂性等问题仍然存在。应对这些挑战对于永续市场成长至关重要。

目录

介绍

  • 研究目的
  • 调查范围
  • 定义

调查方法

  • 资讯采购
  • 二手资料和主要资料方法
  • 市场规模预测
  • 市场假设与限制

执行摘要

  • 全球市场展望
  • 供需趋势分析
  • 按细分市场的机会分析

市场动态及展望

  • 市场概况
  • 市场规模
  • 市场动态
    • 驱动因素和机会
    • 抑制因素和挑战
  • 波特分析与影响
    • 竞争公司之间的敌对关係
    • 替代品的威胁
    • 买方议价能力
    • 新进入者的威胁
    • 供应商的议价能力

主要市场考察

  • 关键成功因素
  • 竞争程度
  • 主要投资机会
  • 市场生态系统
  • 市场吸引力指数(2023)
  • PESTEL分析
  • 总体经济指标
  • 价值链分析
  • 价格分析
  • 技术进步
  • 监管环境
  • 专利分析
  • 案例研究
  • 客户和购买标准分析

胰岛素笔市场规模:按类型

  • 市场概况
  • 可重复使用的胰岛素笔
  • 抛弃式胰岛素笔

胰岛素笔市场规模:依最终用途分类

  • 市场概况
  • 医院/诊所
  • 居家护理
  • 其他的

胰岛素笔市场规模:按地区

  • 北美洲
    • 美国
    • 加拿大
  • 欧洲
    • 英国
    • 德国
    • 西班牙
    • 法国
    • 义大利
    • 其他欧洲国家地区
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 其他亚太地区
  • 拉丁美洲
    • 巴西
    • 其他拉丁美洲地区
  • 中东/非洲
    • 海湾合作委员会国家
    • 南非
    • 其他中东/非洲

竞争资讯

  • 前5名企业对比
  • 主要企业市场定位(2023年)
  • 主要市场参与者所采取的策略
  • 近期市场趋势
  • 公司市场占有率分析(2023)
  • 主要企业简介
    • 公司简介
    • 产品系列分析
    • 按细分市场分類的份额分析
    • 收益与前一年同期比较(2021-2023)

主要企业简介

  • Novo Nordisk A/S
  • Eli Lilly and Company
  • Sanofi
  • Ypsomed Holding AG
  • BD(Becton, Dickinson and Company)
  • Owen Mumford Ltd
  • Haselmeier AG
  • Medtronic plc
  • Emperra GmbH E-Health Technologies
  • Diamesco Co., Ltd.
  • MANNKind Corporation
  • Jiangsu Delfu Medical Device Co., Ltd.
  • Pendiq GmbH
  • Sensile Medical AG
  • Injex Pharma AG
  • Copernicus Sp. z oo
  • Wockhardt Ltd

结论和建议

简介目录
Product Code: SQMIG35B2138

Global Insulin Pens Market size was valued at USD 6.2 billion in 2022 and is poised to grow from USD 7.73 billion in 2023 to USD 44.88 billion by 2031, growing at a CAGR of 24.6% during the forecast period (2024-2031).

The global insulin pens market is experiencing robust growth, driven by the rising prevalence of diabetes and the increasing adoption of insulin pens for their user-friendly and convenient delivery method. These pens are favored for their ease of use, precise dosing, and portability, particularly among the growing diabetic population in developing countries. Awareness of their benefits in diabetes management, alongside technological advancements-such as Bluetooth connectivity and data tracking features-has further propelled market expansion. However, challenges remain, including high costs of advanced models limiting accessibility in low-income regions, inadequate healthcare infrastructure in some areas, and regulatory complexities that manufacturers must navigate to ensure compliance with quality standards. Addressing these challenges is critical for sustained market growth.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Insulin Pens market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Insulin Pens Market Segmental Analysis

Global Insulin Pens Market is segmented by Type, End-use, and region. Based on Type, the market is segmented into Reusable Insulin Pens, and Disposable Insulin Pens. Based on End-use, the market is segmented into Hospitals & Clinics, Homecare, and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Insulin Pens Market

The Global Insulin Pens market is significantly propelled by ongoing technological advancements within insulin pen devices. Innovations such as Bluetooth connectivity, built-in memory functions, and the emergence of smart insulin pens contribute to an enhanced user experience and more effective treatment outcomes. These modern features not only make it easier for patients to manage their diabetes but also promote adherence to treatment regimens. As patients increasingly seek devices that offer both convenience and functionality, these technological improvements are expected to fuel market growth, making insulin pens more appealing and accessible to a wider range of consumers.

Restraints in the Global Insulin Pens Market

The Global Insulin Pens market faces certain constraints primarily due to needle phobia and resistance among some individuals. This aversion to needles can significantly hinder the acceptance and utilization of insulin pens, as many people experience anxiety or fear associated with self-injection. Such apprehensions often lead to decreased adherence to treatment regimens and a preference for alternative methods of insulin delivery. Consequently, the presence of needle-related fears may result in an overall reluctance to adopt insulin pens, posing challenges for market growth and the effective management of diabetes among affected individuals.

Market Trends of the Global Insulin Pens Market

The Global Insulin Pens market is witnessing a significant trend towards customization and personalization, driven by the increasing demand for products that cater to individual patient needs. Manufacturers are responding by offering a variety of options, including a spectrum of colors, adjustable dose settings, and personalized branding features. This movement not only aims to enhance patient engagement and satisfaction but also fosters a sense of ownership among users, making insulin management more user-friendly. As awareness of diabetes continues to rise globally, the push for tailored solutions is expected to dominate the market, influencing product development and healthcare strategies in the coming years.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Driver & Opportunities
    • Restraints & Challenges
  • Porters Analysis & Impact
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2023
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis
  • Technological Advancement
  • Regulatory Landscape
  • Patent Analysis
  • Case Studies
  • Customer & Buying Criteria Analysis

Global Insulin Pens Market Size by Type & CAGR (2024-2031)

  • Market Overview
  • Reusable Insulin Pens
  • Disposable Insulin Pens

Global Insulin Pens Market Size by End-use & CAGR (2024-2031)

  • Market Overview
  • Hospitals & Clinics
  • Homecare
  • Others

Global Insulin Pens Market Size & CAGR (2024-2031)

  • North America, (Type, End-use)
    • US
    • Canada
  • Europe, (Type, End-use)
    • UK
    • Germany
    • Spain
    • France
    • Italy
    • Rest of Europe
  • Asia-Pacific, (Type, End-use)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia Pacific
  • Latin America, (Type, End-use)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa, (Type, End-use)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2023
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2023
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

  • Novo Nordisk A/S
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Eli Lilly and Company
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Sanofi
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Ypsomed Holding AG
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • BD (Becton, Dickinson and Company)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Owen Mumford Ltd
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Haselmeier AG
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Medtronic plc
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Emperra GmbH E-Health Technologies
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Diamesco Co., Ltd.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • MANNKind Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Jiangsu Delfu Medical Device Co., Ltd.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Pendiq GmbH
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Sensile Medical AG
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Injex Pharma AG
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Copernicus Sp. z o.o.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Wockhardt Ltd
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendation